Intracoronary artery thrombolytic infusion

Known as: Intracoronary artery thrombolytic infusion by direct artery injection, infusion or catheterization 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1977-2018
012319772018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ion channels in smooth muscle control coronary vascular tone, but the identity of the potassium channels involved requires… (More)
Is this relevant?
2015
2015
BACKGROUND The use of adult stem cells is limited by the quality and quantity of host stem cells. It has been demonstrated that… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 2
Is this relevant?
2014
2014
OBJECTIVE The aim of this study was to examine the role of intracoronary anisodamine and diltiazem administration performed… (More)
Is this relevant?
2013
2013
OBJECTIVES The study tested the hypothesis that augmentation of the left ventricular (LV) wall thickness with direct… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
This study examined the effects of localized intramyocardial injections of hepatocyte growth factor (HGF) naked DNA plasmid on… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2006
2006
AIM We examined whether there is a differential effect of endothelin-A antagonism on coronary artery compliance in type 2… (More)
Is this relevant?
2003
2003
1. We examined the effects of eprosartan, an AT(1) receptor antagonist, on the progression of left ventricular (LV) dysfunction… (More)
Is this relevant?
1989
1989
We studied the effect of ouabain (digitalis) on the relation between left ventricular (LV) O2 consumption (Vo2) and pressure… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1987
1987
The administration of a drug soon after reperfusion that could enhance myocardial salvage would have important clinical… (More)
Is this relevant?
1983
1983
Intracoronary leukotriene D4, 0.1-3.0 micrograms (0.2-6.0 nmol), produced dose-dependent decreases in coronary flow of… (More)
Is this relevant?